STUDY OBJECTIVES: The primary objective was to systematically review the literature on how sleep disordered breathing (SDB) affects recurrence and death among stroke or transient ischemic attack (TIA) patients. A secondary objective was to evaluate how treatment of SDB with continuous positive airway pressure (CPAP) affects the risk of recurrence and death in these patients. METHODS: Adults (18+) with a stroke or TIA diagnosis were eligible for inclusion. Case groups consisted of patients with a sleep disorder. The outcomes of interest were all-cause mortality, recurrent vascular events, and case fatality. RESULTS: Ten articles covering 1,203 stroke and TIA patients were included in the review. The results generally support a dose-response relationship between severity of SDB and risk of recurrent events and all-cause mortality in stroke and TIA patients. Three small-scale articles with substantial risk of bias evaluated the effects of CPAP therapy, and the results are inconclusive. Data on case fatality is too sparse to be conclusive. CONCLUSIONS: Existing studies provide sufficient data to establish obstructive SDB as a negative predictor of all-cause mortality and recurrent vascular events following stroke or TIA. The ability of CPAP treatment to lower the risk of serious adverse outcomes after stroke remains controversial because of substantial risk of bias identified in most of the eligible studies addressing this relation. Additional studies are needed.
STUDY OBJECTIVES: The primary objective was to systematically review the literature on how sleep disordered breathing (SDB) affects recurrence and death among stroke or transient ischemic attack (TIA) patients. A secondary objective was to evaluate how treatment of SDB with continuous positive airway pressure (CPAP) affects the risk of recurrence and death in these patients. METHODS: Adults (18+) with a stroke or TIA diagnosis were eligible for inclusion. Case groups consisted of patients with a sleep disorder. The outcomes of interest were all-cause mortality, recurrent vascular events, and case fatality. RESULTS: Ten articles covering 1,203 stroke and TIApatients were included in the review. The results generally support a dose-response relationship between severity of SDB and risk of recurrent events and all-cause mortality in stroke and TIApatients. Three small-scale articles with substantial risk of bias evaluated the effects of CPAP therapy, and the results are inconclusive. Data on case fatality is too sparse to be conclusive. CONCLUSIONS: Existing studies provide sufficient data to establish obstructive SDB as a negative predictor of all-cause mortality and recurrent vascular events following stroke or TIA. The ability of CPAP treatment to lower the risk of serious adverse outcomes after stroke remains controversial because of substantial risk of bias identified in most of the eligible studies addressing this relation. Additional studies are needed.
Authors: Susan Redline; Gayane Yenokyan; Daniel J Gottlieb; Eyal Shahar; George T O'Connor; Helaine E Resnick; Marie Diener-West; Mark H Sanders; Philip A Wolf; Estella M Geraghty; Tauqeer Ali; Michael Lebowitz; Naresh M Punjabi Journal: Am J Respir Crit Care Med Date: 2010-03-25 Impact factor: 21.405
Authors: Michael Arzt; Terry Young; Laurel Finn; James B Skatrud; T Douglas Bradley Journal: Am J Respir Crit Care Med Date: 2005-09-01 Impact factor: 21.405
Authors: Rainier Dziewas; Marius Humpert; Benjamin Hopmann; Stephan P Kloska; Peter Lüdemann; Martin Ritter; Ralf Dittrich; E Bernd Ringelstein; Peter Young; Darius G Nabavi Journal: J Neurol Date: 2005-07-20 Impact factor: 4.849
Authors: R Rola; H Jarosz; A Wierzbicka; A Wichniak; P Richter; D Ryglewicz; W Jernajczyk Journal: J Physiol Pharmacol Date: 2008-12 Impact factor: 3.011
Authors: Rainer Dziewas; Benjamin Hopmann; Marius Humpert; Martin Ritter; Ralf Dittrich; Wolf R Schäbitz; E Bernd Ringelstein; Darius G Nabavi; Peter Young Journal: Neurol Res Date: 2008-04-18 Impact factor: 2.448
Authors: Filip Alexiev; Anne-Kathrin Brill; Sebastian R Ott; Simone Duss; Markus Schmidt; Claudio L Bassetti Journal: J Thorac Dis Date: 2018-12 Impact factor: 2.895